Key facts
- Infix’s last known valuation is $7.6M (Dec 2024).
- It has raised $1.9M; the latest was Accelerator/Incubator in Apr 2025.
- Notable investors include Innovate UK, Association of British Healthtech Industries, Scottish EDGE.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Infix
- ·The full record, as it builds
Funding rounds
No funding rounds for Infix are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Infix
Developer of a cloud-based patient database integration platform designed to integrate EPR systems to improve theatre planning and efficiency. The company's platform offers tools that feature theatre scheduling, patient pre-assessment, theatre checklists, and reporting which can help to reduce turnaround times, which can lead to increased patient throughput, enabling healthcare organizations to improve theatre time efficiencies and utilization, while also reducing the administrative burden on staff.
- Sector
- Healthcare
- HQ
- Glasgow, United Kingdom
- Founded
- 2019
- Employees
- 10
- Website
- infixsupport.com/
- Ownership
- Privately Held (backing)
Infix doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Infix shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Infix in its N-PORT filings yet. We sweep new filings monthly.